Document ID: chunk:federal_register_of_legislation:F2023L00742:clause:2_4
Version: federal_register_of_legislation:F2023L00742
Segment Type: clause
Provision Reference: sch 2 cl 4
Character Range: 1670–4258

4  Definitions
Note: A number of expressions used in this instrument are defined in section 3 of the Act, including the following:
(a) Secretary.
  In this instrument:
Act means the Therapeutic Goods Act 1989.
advisory committee means an advisory committee that is established under Part 6 of the Regulations and includes any of the committees previously established under the Regulations.
advisory committee advice means advice or recommendations provided by an advisory committee to the Minister or the Secretary in relation to a matter or item considered by an advisory committee at an advisory committee meeting.
meeting statement means a description of outcomes arising from an advisory committee meeting.
relevant persons or bodies means any of the following bodies, and employees, members or agents of these bodies:
 (a) the Advisory Committee on Biologicals (ACB), and any subcommittee of the ACB;
 (b) the Advisory Committee on Chemicals Scheduling (ACCS), and any subcommittee of the ACCS;
 (c) the Advisory Committee on Complementary Medicines (ACCM), and any subcommittee of the ACCM;
 (d) the Advisory Committee on Medical Devices (ACMD), and any subcommittee of the ACMD;
 (e) the Advisory Committee on Medicines (ACM), and any subcommittee of the ACM;
 (f) the Advisory Committee on Medicines Scheduling (ACMS), and any subcommittee of the ACMS;
 (g) the Advisory Committee on Vaccines (ACV), and any subcommittee of the ACV;
 (h) the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR);
 (i) the Australian Technical Advisory Group on Immunisation (ATAGI);
 (j) the Cardiac Prostheses Clinical Advisory Group;
 (k) the Cardiothoracic Prostheses Clinical Advisory Group;
 (l) the Hip Prostheses Clinical Advisory Group;
 (m) the Knee Prostheses Clinical Advisory Group;
 (n) the Medical Devices and Human Tissue Advisory Committee (MDHTAC), and any subcommittee of the MDHTAC;
 (o) the Medical Services Advisory Committee (MSAC), and any subcommittee of the MSAC;
 (p) the National Centre for Immunisation Research and Surveillance (NCIRS);
 (q) the National Immunisation Committee (NIC);
 (r) the Ophthalmic Prostheses Clinical Advisory Group;
 (s) the Pharmaceutical Benefits Advisory Committee (PBAC), and any subcommittee of the PBAC;
 (t) the Specialist Orthopaedic Clinical Advisory Group;
 (u) the Spinal Prostheses Clinical Advisory Group;
 (v) the Vascular Prostheses Clinical Advisory Group.
Regulations mean the Therapeutic Goods Regulations 1990.
therapeutic goods information has the meaning given by subsection 61(1) of the Act.